Abstract
Dual-specificity tyrosine phosphorylation-regulated kinases (DYRKs) constitute an evolutionarily conserved family of protein kinases with key roles in the control of cell proliferation and differentiation. Members of the DYRK family phosphorylate many substrates, including critical regulators of the cell cycle. A recent report revealed that human DYRK2 acts as a negative regulator of G1/S transition by phosphorylating c-Jun and c-Myc, thereby inducing ubiquitination-mediated degradation. Other DYRKs also function as cell cycle regulators by modulating the turnover of their target proteins. DYRK1B can induce reversible cell arrest in a quiescent G0 state by targeting cyclin D1 for proteasomal degradation and stabilizing p27Kip1. The DYRK2 ortholog of C. elegans, MBK-2, triggers the proteasomal destruction of oocyte proteins after meiosis to allow the mitotic divisions in embryo development. This review summarizes the accumulating results that provide evidence for a general role of DYRKs in the regulation of protein stability.
Keywords: DYRK1A, DYRK1B, DYRK2, HIPK2, MBK-2, Yak1, p27Kip1, phosphodegron, ubiquitin cyclin D1
DYRK Family Protein Kinases
Kinases of the DYRK family were discovered as key regulators of cell growth and differentiation in genetically tractable organisms such as budding yeast (Yak1), fission yeast (Pom1), Dictyostelium (YakA) and Drosophila (MNB).1,2 Human DYRK1A was discovered as the product of a gene localized in the Down syndrome critical region on chromosome 21.3 DYRK1A has been most extensively studied among the mammalian DYRKs, because its overexpression in trisomy 21 is believed to contribute to the neuropathological traits of Down syndrome.4,5 DYRK1A and the closely related DYRK1B (also known as MIRK) have also been characterized as negative regulators of the cell cycle that mediate cell survival and promote the switch to a quiescent state or differentiation.6-9 DYRK2 can induce apoptosis upon genotoxic stress by phosphorylating p53.10 Although members of the DYRK family are engaged in multiple and diverse regulatory processes in different experimental systems, a recurrent theme of their functions in mammalian cells as well as in yeasts, C. elegans and Dictyostelium is their role as key regulators of different checkpoints in the cell cycle.
Target Proteins of DYRKs
An increasing number of substrates and functions in signal transduction pathways is being reported for DYRKs from different organisms. Downstream effects mediated by target proteins of DYRKs include the increased activity of transcription factors, the modulation of subcellular protein distribution and the regulation of enzyme activity. Recent reviews provide an excellent overview of the biochemical properties and the currently known substrates of DYRK1A as well as the other kinases of the DYRK family.2,11 One characteristic feature of several DYRK kinases is their function as priming kinases, meaning that the phosphorylation of a given residue by a DYRK is prerequisite for the subsequent phosphorylation of a different residue by another protein kinase (GSK3 or PLK).2 Here we want to call attention to another effect common to several members of the DYRK family, namely the control of protein stability. This function of DYRKs has been brought into the limelight by a new report from Taira et al.,12 who identified DYRK2 as the kinase controlling c-Jun and c-Myc degradation at the G1/S boundary. This finding adds to accumulating evidence that members of the DYRK family from diverse organisms modulate the turnover of target proteins either by inducing degradation by the ubiquitin-proteasome system (UPS), or by stabilizing short-lived proteins.
This review summarizes the current knowledge that DYRKs function in the regulation of protein stability. Emphasis is placed on proteins involved in cell cycle control, and the scope is limited to the members of the DYRK subfamily. It should be noticed, however, that the closely related homeodomain-interacting protein kinase 2 (HIPK2) has also been reported to regulate the turnover of some target proteins. Exemplary data for HIPK2 are included in Table 1, which lists the published evidence for the regulation of protein turnover by the DYRK family.
Table 1. Evidence for a role of DYRKs as regulators of protein stability.
Kinase |
Protein (phosphorylation sites) |
GSK3 priming |
Function |
Comments |
Ref |
---|---|---|---|---|---|
Protein degradation | |||||
DYRK2 |
c-Jun (S239) |
yes |
regulation of S-phase entry |
DYRK2 /GSK3 initiate ubiquitination via Fbw7 E3 ligase |
12 |
DYRK2 |
c-Myc (S62) |
yes |
regulation of S-phase entry |
DYRK2 /GSK3 initiate ubiquitination via Fbw7 E3 ligase |
12 |
DYRK2 |
GLI2 (S385, S1011) |
|
effector of hedgehog pathway |
DYRK2 reduces GLI2 levels, MG132 inhibitable |
17 |
DYRK2 |
katanin p60 (S42, S109, T133) |
|
control of mitotic transition |
DYRK2 serves as a scaffold for EDVP E3 ligase |
14 |
MBK-2 |
MEI-1 (katanin) |
|
oocyte-to-embryo transition |
MBK-2 initiates APC dependent degradation |
21,22 |
MBK-2 |
OMA-1 (T239), OMA-2 |
yes |
oocyte-to-embryo transition |
MBK-2/GSK3 initiate ubiquitination by CUL2-based E3 ligase |
19,20 |
DYRK1B DYRK1A |
cyclin D1 (T286 or T288) |
no |
regulation of S-phase entry |
phosphorylation initiates SCFFbx4/αB-crystallin-mediated degradation |
23, 26 |
DYRK1A |
REST |
|
neuronal differentiation |
no direct evidence for phospho-degron; degraded via SCFβ-TrCP |
35 |
DYRK1A |
CRY2 (S557) |
yes |
component of circadian clock |
SCFFbxl3-independent, MG132 sensitive |
54 |
HIPK2 |
CtBP (S422) |
|
transcriptional co-repressor |
HIPK2 is required for the UV-induced decrease in CtBP |
55 |
HIPK2 |
ZBTB4 (T783, T795, T797) |
|
regulator of p21 expression |
HIPK2 is required for the UV-induced decrease in ZBTB4 |
56 |
HIPK2 |
ΔNp63 (T397) |
|
prosurvival factor |
HIPK2 is required for DNA damage-induced degradation of ΔNp63 |
57 |
HIPK2 |
β catenin (S33,S37) |
no |
effector of Wnt pathway |
phosphorylation initiates SCFβ-TrCP-mediated degradation |
58 |
HIPK2 |
Siah2 (S26,S28,S36) |
no |
E3 ligase involved in hypoxic regulation |
phosphorylation reduces the half-life of Siah2 |
59 |
Yak1 |
cyclin B2 |
|
regulatory subunit of CDK |
genetic evidence for enhanced APC-dependent degradation of cyclin B2 |
50 |
Protein stabilization | |||||
---|---|---|---|---|---|
DYRK1B HIPK2 |
p27Kip1 (S10) |
|
CDK inhibitor |
phosphorylation enhances stability of p27 (by preventing nuclear export) |
24,47 |
DYRK1A |
HPV16E7 (Thr5, Thr7) |
|
Viral oncoprotein |
phosphorylation enhances stability |
48 |
DYRK1A |
Presenilin 1 (T354) |
|
component of gamma secretase complex |
phosphorylation enhances stability |
60 |
DYRK1A |
RCAN1 (T192) |
|
inhibition of NFAT activation by calcineurin |
phosphorylation enhances stability |
61 |
Protein interaction | |||||
---|---|---|---|---|---|
DYRK1A/B HIPK2 |
DCAF7( = WDR68) |
|
putative substrate receptor of CUL4-type E3 ligases |
scaffold of HIPK2 complexes; DYRK1A recruits DCAF7 to the nucleus |
40,41 |
DYRK1A |
CUL9 ( = PARC) |
|
atypical E3 ligase |
identified in interaction screen |
43 |
DYRK1A |
RNF216 |
|
E3 ligase |
identified in interaction screen |
43 |
DYRK2 |
DCAF1 ( = VprBP) |
|
substrate receptor of CUL4-type E3 ligases |
identified by tandem affinity purification |
14 |
Yak1 | Hrt1 ( = ROC1) | E2 recruiting subunit of SCF | identified in interaction screen | 41 |
The table lists the DYRK substrates that are either destabilized or stabilized by phosphorylation and DYRK interacting proteins related to ubiquitin E3 ligases. The table includes proteins that are not related to cell cycle control as well as target proteins of HIPK2 that are not further discussed in the text
DYRK2 Initiates Protein Degradation via the UPS
Two major types of E3 ubiquitin ligase complexes catalyze the phase-specific ubiquitination of proteins in the cell cycle, the anaphase-promoting complex (APC) multisubunit E3 ligase and the SCF form of E3 ligases. SCF E3 ligases belong to the major group of cullin-based E3 ligases, which consist of four kinds of protein subunits: an adaptor protein (Skp1 in SCF), a scaffold protein termed a cullin (CUL1 in SCF), an E2-recruiting subunit (Roc1/Rbx1/Hrt1) and a substrate receptor (one of about 70 F-box proteins in SCF).13 Phosphorylation-dependent protein degradation is a common mechanism for regulating protein stability in a cell cycle-dependent or stimulus-dependent manner. Kinases create phosphodegron motifs in the substrate proteins, which are then recognized by F-box proteins and ubiquitinated by E3 ligase complexes.
The recent study of Taira et al.12 reveals interesting details about the molecular mechanism by which DYRK2 regulates the turnover of c-Myc and c-Jun. Many tumor cells depend on high levels of c-Jun and c-Myc to enter S phase. Cellular levels of these oncogenic transcription factors are controlled by proteasomal degradation, which is initiated upon phosphorylation by GSK3β. DYRK2 has now been identified as the priming kinase for the phosphorylation of c-Jun and c-Myc by GSK3β, meaning that phosphorylation of the substrate at the P+4 position by DYRK2 is required for substrate recognition by GSK3β.12 The subsequent phosphorylation of the P0 residue by GSK3β creates a phosphodegron required for the binding of an SCF E3 ligase complex containing the F-box protein Fbw7, eventually resulting in the polyubiquitination and ensuing proteasomal degradation of c-Jun/c-Myc (Fig. 1). DYRK2 was shown to play a key role in this chain of events, since the knockdown of DYRK2 in human cancer cells shortened the G1 phase and accelerated cell proliferation due to the escape of c-Jun and c-Myc from ubiquitination-mediated degradation.
Figure 1. DYRK2 targets c-Myc for ubiquitination and destruction. Phosphorylation of Ser62 by DYRK2 primes c-Myc for phosphorylation at Thr58 by GSK3β. The resulting phosphodegron motif is recognized by Fbw7, which acts as the substrate receptor of an SCF complex (SKP1/cullin1/Fbw7/Rbx), initiating ubiquitination by the E2 ligase and subsequent proteasomal degradation. Likewise, c-Jun is ubiquitinated after sequential phosphorylation at Thr239 and Ser243 by DYRK2 and GSK3β.12
DYRK2 has been reported to function as a scaffold for the assembly of an E3 ligase complex with a protein composition similar to cullin4A-RING E3 ubiquitin ligase (CRL4) but lacking the cullin protein.14 This complex was shown to catalyze the phosphorylation and subsequent ubiquitination of katanin p60, a microtubule-severing enzyme with an important role in the mitotic reorganization of spindle microtubules. The authors have proposed that the catalytic domain of DYRK2 harbors a KELCH motif, which is a feature of several proteins acting as E3 ligase adaptors for specific substrates. Functional KELCH motifs allow for many substitutions and cannot unambiguously be identified by the sequence alone. However, the organization as a twisted β-sheet motif arranged in a propeller-like structure is invariable.15 The existence of a functional KELCH repeat at the position suggested (amino acid residues 390–433) must be excluded, because this region of DYRK2, as in all protein kinases, is made up by α helices (PDB accession 3KVW).
Another target of DYRK2 is the transcription factor GLI2, a primary downstream effector of the hedgehog pathway with a proliferative effect in many tumors.16 Phosphorylation by DYRK2 induces the degradation of GLI2 by the UPS.17 A previous study had identified a phosphodegron for recognition by the SCFβ-TrCP2 E3 ligase and proposed GSK3 as the relevant kinase.18 However, there is no evidence for a priming function of DYRK2, and it is also not known whether the DYRK2 phosphorylation sites directly control binding of an E3 ligase. Further research is required to reveal the individual or synergistic roles of DYRK2 and GSK3 in the regulation of GLI2 turnover.
It is remarkable that the ortholog of DYRK2 in C. elegans, MBK-2, has also a critical function in the control of protein degradation. Due to the availability of both genetic and cell biological methods, the role of MBK-2 in C. elegans embryogenesis has been characterized in great molecular and functional detail. MBK-2 is activated in zygotes at meiosis II and phosphorylates three proteins, MEI-1, OMA-1 and OMA-2, promoting their timely degradation to allow oocyte-to-embryo transition.19-21 MBK-2 acts as priming kinase initiating phosphorylation of OMA-1 by GSK3 and subsequent recognition by a CUL2-based E3 ligase.19,20 MEI-1 is the ortholog of mammalian katanin and is required in meiotic spindle organization but must be inactivated prior to mitosis. Phosphorylation by MBK-2 initiates the degradation of MEI-1 via APC-dependent ubiquitination.22
Roles of DYRK1A and DYRK1B in the Regulation of Protein Stability
The first results pointing to a role of DYRKs in cell cycle control via regulation of protein stability have been obtained in pioneering studies of DYRK1B.23,24 DYRK1B destabilizes cyclin D1 by phosphorylating a threonine residue close to the C terminus.23,25 A recent report suggests that DYRK1A can also catalyze this phosphorylation, leading to nuclear export and proteasomal degradation of cyclin D1.26 The exact site of phosphorylation (Thr286 or Thr288) is controversial, but it is clear that in this case, DYRK1A and DYRK1B do not act as priming kinases for GSK3. Phosphorylation on Thr286 by GSK3 in S phase is known to induce the cytoplasmic ubiquitination of cyclin D1 catalyzed by SCFFbx4/αB-crystallin E3 ligase.27 DYRK1B rather appears to act in G0/G1 to maintain cells in growth arrest and quiescence by depleting cyclin D1.22 In neurons, DYRK1A overexpression leads to the nuclear export and degradation of cyclin D1.28 Importantly, cyclin D1 also plays a role in p27Kip1 proteolysis, in the sense that loss of cyclin D1 causes accumulation of p27 (see below).29 The importance of cyclin D1 proteolysis for normal cell homeostasis is highlighted by the fact that mutations in the cyclin D1 phosphodegron have been observed in human tumors.30 It is worth mentioning that cyclin D2 and cyclin D3 are also phosphorylated on corresponding C-terminal threonines (Thr280 and Thr283, respectively) to trigger their UPS-dependent degradation.31-33 It remains to be determined whether DYRK1A and/or DYRK1B also phosphorylate these cyclins.
The RE1-silencing transcription factor (REST) is expressed in dividing neural progenitors and acts as a repressor of neuronal differentiation and positive regulator of proliferation.34 The neurodevelopmental effects of DYRK1A in Down syndrome may in part be due its effect on REST, since DYRK1A overexpression reduces REST protein levels through facilitating ubiquitination and subsequent degradation.35 REST is regulated by phosphorylation and subsequent ubiquitin-mediated proteolysis in a SCFβ‑TRCP E3 ligase-dependent manner,36 but it remains to be shown whether DYRK1A acts on this pathway. Reduced REST levels due to DYRK1A overexpression were documented from undifferentiated embryonic stem cells to adult brain and are predicted to favor cell cycle exit and differentiation of neural progenitor cells.37
Another strong indication that DYRK1A and DYRK1B are functionally linked with E3 ubiquitin ligases is the fact that both of them, as well as HIPK2 (but not DYRK2), have repeatedly been shown to interact with DDB1 and CUL4-associated factor 7 (DCAF7, also called WDR68 or Han11).38-41 DCAFs are a family of more than 50 proteins that function as adaptor proteins of the CUL4-DDB1 ubiquitin ligases to mediate substrate specificity.42 The specific function of DCAF7 as a receptor subunit of E3 ligase complexes is unknown, but one might speculate that it mediates the interaction either between the kinase and its substrate or between the kinase and an E3 ligase. Another protein interacting with DYRK1A is cullin 9,43 which seems to be part of an atypical cullin-based E3 ligase complex and regulates p53.44
Stabilization of Target Proteins by DYRK1A and DYRK1B
In addition to targeting specific proteins for proteasomal degradation, DYRK1A or DYRK1B can stabilize other proteins by phosphorylation. The most pertinent example in this context is the phosphorylation by DYRK1B of p27Kip1 on Ser10 during the G0 phase of the cell cycle.24 p27 is a CDK inhibitor that controls the transition from the G1 into the S phase of the cell cycle. Phosphorylation on Ser10 stabilizes p27 in quiescent cells by maintaining the protein within the nucleus, where it inhibits CDK2.45 The physiological importance of Ser10 phosphorylation was shown in lymphocytes from p27S10A/ S10A‑knock-in mice, where protein turnover of p27 in G0 phase, but not in S phase, was markedly enhanced compared with wild-type cells. Phosphorylation of Ser10 in G1 phase or upon mitogenic stimulation is catalyzed by other kinases and has different functional consequences as compared with G0.46 Recently, HIPK2 has also been shown to phosphorylate Ser10 and stabilize p27 in asynchronously growing cell lines.47 Further work will be necessary to uncover the contribution of the individual kinases in different cell types and different phases of the cell cycle.
The E7 oncoprotein of human papilloma virus type 16 (HPV16E7) is another substrate of DYRK1A and has been reported to be stabilized by phosphorylation on Thr5 and Thr7.48 HPV16E7 induces the degradation of retinoblastoma family of proteins (pRb, p107 and p130) and promotes S phase entry. Phosphorylation by DYRK1A increased the half-life of HPV16E7 and enhanced the transforming potential of HPV16-infected cells. This effect is in striking contrast to the antiproliferative effects of DYRK1A or DYRK1B that result from phosphorylation of cyclin D1 or p27. Thus, the viral oncoprotein virtually hijacks and reprograms a cellular pathway that normally inhibits cell division.
Other Members of the DYRK Family
Yak1 is the first known DYRK and the only member of the family in Saccharomyces cerevisiae. The Yak1 gene was identified in a genetic screen as a negative regulator of growth that is induced by arrest early in the cell cycle.49 Furthermore, overexpression of Yak1 suppressed defects in the degradation of cyclin B by the APC-ubiquitin-proteasome pathway, suggesting that the Yak1 kinase enhances the APC-mediated ubiquitination of cyclin B.50 A large-scale interaction screen identified Yak1 as a protein binding to the Hrt1 component of the SCF E3 ligase complex.51 Collectively, these results suggest that Yak1 may also be implicated in the regulation of protein turnover, but this point has not yet been addressed biochemically.
Conclusions and Perspectives
In conclusion, many pieces of evidence support the hypothesis that DYRK family kinases fulfill evolutionarily ancient functions in the regulation of protein turnover, either by the triggering UPS-mediated degradation or by enhancing the stability of target proteins. In line with the known roles of DYRKs in the regulation of cell proliferation and differentiation, many of the proteins whose abundance is modulated by DYRKs are involved in cell cycle control. Obviously, the effect on protein stability is not the only mechanisms by which DYRKs act as cell cycle regulators. For example, the proapoptotic effects of DYRK2 by phosphorylation of p53 and the role of DYRK1A in cell cycle exit by promoting assembly of the DREAM (DP, Retinoblastoma, E2F and MuvB) complex do not involve direct effects of DYRKs on protein turnover.8,9,52 Moreover, DYRK1A upregulates p27Kip1 levels not only by protein stabilization, but also by transcriptional regulation.53
It appears likely that more examples for a role of DYRKs as regulators of protein turnover will emerge, both in the regulation of the cell cycle and other cellular processes. Important tasks for the future include the elucidation not only of the exact mechanism of the interaction between DYRKs and the relevant E3 ligases, but also of the mechanism by which DYRKs can reduce the turnover of specific substrates (such as p27Kip1).
Acknowledgments
Financial support of my group’s research on DYRKs by the Deutsche Forschungsgemeinschaft is gratefully acknowledged (BE 1967/2–1). I thank Georgios Stefos for diligent proofreading.
Glossary
Abbreviations:
- APC
anaphase-promoting complex
- DCAF
DDB1 and CUL4-associated factor
- DYRK
dual-specificity tyrosine phosphorylation-regulated kinase
- HIPK
homeodomain-interacting protein kinase
- REST
RE1 silencing transcription factor
- SCF
E3 ligase complex containing Skp, cullin and F-box protein
- UPS
ubiquitin proteasome system
Footnotes
Previously published online: www.landesbioscience.com/journals/cc/article/21404
References
- 1.Becker W, Joost HG. Structural and functional characteristics of Dyrk, a novel subfamily of protein kinases with dual specificity. Prog Nucleic Acid Res Mol Biol. 1999;62:1–17. doi: 10.1016/S0079-6603(08)60503-6. [DOI] [PubMed] [Google Scholar]
- 2.Aranda S, Laguna A, de la Luna S. DYRK family of protein kinases: evolutionary relationships, biochemical properties, and functional roles. FASEB J. 2011;25:449–62. doi: 10.1096/fj.10-165837. [DOI] [PubMed] [Google Scholar]
- 3.Guimerá J, Casas C, Pucharcòs C, Solans A, Domènech A, Planas AM, et al. A human homologue of Drosophila minibrain (MNB) is expressed in the neuronal regions affected in Down syndrome and maps to the critical region. Hum Mol Genet. 1996;5:1305–10. doi: 10.1093/hmg/5.9.1305. [DOI] [PubMed] [Google Scholar]
- 4.Hämmerle B, Elizalde C, Galceran J, Becker W, Tejedor FJ. The MNB/DYRK1A protein kinase: neurobiological functions and Down syndrome implications. J Neural Transm Suppl. 2003;67:129–37. doi: 10.1007/978-3-7091-6721-2_11. [DOI] [PubMed] [Google Scholar]
- 5.Park J, Song WJ, Chung KC. Function and regulation of Dyrk1A: towards understanding Down syndrome. Cell Mol Life Sci. 2009;66:3235–40. doi: 10.1007/s00018-009-0123-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Mercer SE, Friedman E. Mirk/Dyrk1B: a multifunctional dual-specificity kinase involved in growth arrest, differentiation, and cell survival. Cell Biochem Biophys. 2006;45:303–15. doi: 10.1385/CBB:45:3:303. [DOI] [PubMed] [Google Scholar]
- 7.Friedman E. Mirk/Dyrk1B in cancer. J Cell Biochem. 2007;102:274–9. doi: 10.1002/jcb.21451. [DOI] [PubMed] [Google Scholar]
- 8.Litovchick L, Florens LA, Swanson SK, Washburn MP, DeCaprio JA. DYRK1A protein kinase promotes quiescence and senescence through DREAM complex assembly. Genes Dev. 2011;25:801–13. doi: 10.1101/gad.2034211. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Tschöp K, Conery AR, Litovchick L, Decaprio JA, Settleman J, Harlow E, et al. A kinase shRNA screen links LATS2 and the pRB tumor suppressor. Genes Dev. 2011;25:814–30. doi: 10.1101/gad.2000211. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Yoshida K. Role for DYRK family kinases on regulation of apoptosis. Biochem Pharmacol. 2008;76:1389–94. doi: 10.1016/j.bcp.2008.05.021. [DOI] [PubMed] [Google Scholar]
- 11.Tejedor FJ, Hämmerle B. MNB/DYRK1A as a multiple regulator of neuronal development. FEBS J. 2011;278:223–35. doi: 10.1111/j.1742-4658.2010.07954.x. [DOI] [PubMed] [Google Scholar]
- 12.Taira N, Mimoto R, Kurata M, Yamaguchi T, Kitagawa M, Miki Y, et al. DYRK2 priming phosphorylation of c-Jun and c-Myc modulates cell cycle progression in human cancer cells. J Clin Invest. 2012;122:859–72. doi: 10.1172/JCI60818. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Spruck CH, Strohmaier HM. Seek and destroy: SCF ubiquitin ligases in mammalian cell cycle control. Cell Cycle. 2002;1:250–4. [PubMed] [Google Scholar]
- 14.Maddika S, Chen J. Protein kinase DYRK2 is a scaffold that facilitates assembly of an E3 ligase. Nat Cell Biol. 2009;11:409–19. doi: 10.1038/ncb1848. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Hudson AM, Cooley L. Phylogenetic, structural and functional relationships between WD- and Kelch-repeat proteins. Subcell Biochem. 2008;48:6–19. doi: 10.1007/978-0-387-09595-0_2. [DOI] [PubMed] [Google Scholar]
- 16.Lauth M, Toftgård R. Non-canonical activation of GLI transcription factors: implications for targeted anti-cancer therapy. Cell Cycle. 2007;6:2458–63. doi: 10.4161/cc.6.20.4808. [DOI] [PubMed] [Google Scholar]
- 17.Varjosalo M, Björklund M, Cheng F, Syvänen H, Kivioja T, Kilpinen S, et al. Application of active and kinase-deficient kinome collection for identification of kinases regulating hedgehog signaling. Cell. 2008;133:537–48. doi: 10.1016/j.cell.2008.02.047. [DOI] [PubMed] [Google Scholar]
- 18.Bhatia N, Thiyagarajan S, Elcheva I, Saleem M, Dlugosz A, Mukhtar H, et al. Gli2 is targeted for ubiquitination and degradation by beta-TrCP ubiquitin ligase. J Biol Chem. 2006;281:19320–6. doi: 10.1074/jbc.M513203200. [DOI] [PubMed] [Google Scholar]
- 19.Nishi Y, Lin R. DYRK2 and GSK-3 phosphorylate and promote the timely degradation of OMA-1, a key regulator of the oocyte-to-embryo transition in C. elegans. Dev Biol. 2005;288:139–49. doi: 10.1016/j.ydbio.2005.09.053. [DOI] [PubMed] [Google Scholar]
- 20.Shirayama M, Soto MC, Ishidate T, Kim S, Nakamura K, Bei Y, et al. The conserved kinases CDK-1, GSK-3, KIN-19, and MBK-2 promote OMA-1 destruction to regulate the oocyte-to-embryo transition in C. elegans. Curr Biol. 2006;16:47–55. doi: 10.1016/j.cub.2005.11.070. [DOI] [PubMed] [Google Scholar]
- 21.Stitzel ML, Pellettieri J, Seydoux G. The C. elegans DYRK kinase MBK-2 marks oocyte proteins for degradation in response to meiotic maturation. Curr Biol. 2006;16:56–62. doi: 10.1016/j.cub.2005.11.063. [DOI] [PubMed] [Google Scholar]
- 22.Lu C, Mains PE. The C. elegans anaphase promoting complex and MBK-2/DYRK kinase act redundantly with CUL-3/MEL-26 ubiquitin ligase to degrade MEI-1 microtubule-severing activity after meiosis. Dev Biol. 2007;302:438–47. doi: 10.1016/j.ydbio.2006.09.053. [DOI] [PubMed] [Google Scholar]
- 23.Zou Y, Ewton DZ, Deng X, Mercer SE, Friedman E. Mirk/dyrk1B kinase destabilizes cyclin D1 by phosphorylation at threonine 288. J Biol Chem. 2004;279:27790–8. doi: 10.1074/jbc.M403042200. [DOI] [PubMed] [Google Scholar]
- 24.Deng X, Mercer SE, Shah S, Ewton DZ, Friedman E. The cyclin-dependent kinase inhibitor p27Kip1 is stabilized in G(0) by Mirk/dyrk1B kinase. J Biol Chem. 2004;279:22498–504. doi: 10.1074/jbc.M400479200. [DOI] [PubMed] [Google Scholar]
- 25.Takahashi-Yanaga F, Mori J, Matsuzaki E, Watanabe Y, Hirata M, Miwa Y, et al. Involvement of GSK-3beta and DYRK1B in differentiation-inducing factor-3-induced phosphorylation of cyclin D1 in HeLa cells. J Biol Chem. 2006;281:38489–97. doi: 10.1074/jbc.M605205200. [DOI] [PubMed] [Google Scholar]
- 26.Blockeel A, Oxley D, Cook SJ, Lochhead PA. DYRK1A and DYRK1B phosphorylate cyclin D1 on Thr286 to promote cyclin D1 turnover. Poster P021 presented at “Signalling 2011: A Biochemical Society Centenary Celebration” Edinburgh 2011. [Google Scholar]
- 27.Barbash O, Diehl JA. SCF(Fbx4/alphaB-crystallin) E3 ligase: when one is not enough. Cell Cycle. 2008;7:2983–6. doi: 10.4161/cc.7.19.6775. [DOI] [PubMed] [Google Scholar]
- 28.Yabut O, Domogauer J, D’Arcangelo G. Dyrk1A overexpression inhibits proliferation and induces premature neuronal differentiation of neural progenitor cells. J Neurosci. 2010;30:4004–14. doi: 10.1523/JNEUROSCI.4711-09.2010. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Jonason JH, Gavrilova N, Wu M, Zhang H, Sun H. Regulation of SCF(SKP2) ubiquitin E3 ligase assembly and p27(KIP1) proteolysis by the PTEN pathway and cyclin D1. Cell Cycle. 2007;6:951–61. doi: 10.4161/cc.6.8.4104. [DOI] [PubMed] [Google Scholar]
- 30.Benzeno S, Lu F, Guo M, Barbash O, Zhang F, Herman JG, et al. Identification of mutations that disrupt phosphorylation-dependent nuclear export of cyclin D1. Oncogene. 2006;25:6291–303. doi: 10.1038/sj.onc.1209644. [DOI] [PubMed] [Google Scholar]
- 31.Casanovas O, Jaumot M, Paules AB, Agell N, Bachs O. P38SAPK2 phosphorylates cyclin D3 at Thr-283 and targets it for proteasomal degradation. Oncogene. 2004;23:7537–44. doi: 10.1038/sj.onc.1208040. [DOI] [PubMed] [Google Scholar]
- 32.Naderi S, Gutzkow KB, Låhne HU, Lefdal S, Ryves WJ, Harwood AJ, et al. cAMP-induced degradation of cyclin D3 through association with GSK-3beta. J Cell Sci. 2004;117:3769–83. doi: 10.1242/jcs.01210. [DOI] [PubMed] [Google Scholar]
- 33.Kida A, Kakihana K, Kotani S, Kurosu T, Miura O. Glycogen synthase kinase-3beta and p38 phosphorylate cyclin D2 on Thr280 to trigger its ubiquitin/proteasome-dependent degradation in hematopoietic cells. Oncogene. 2007;26:6630–40. doi: 10.1038/sj.onc.1210490. [DOI] [PubMed] [Google Scholar]
- 34.Das CM, Taylor P, Gireud M, Singh A, Lee D, Fuller G, et al. The deubiquitylase USP37 links REST to the control of p27 stability and cell proliferation. Oncogene. 2012 doi: 10.1038/onc.2012.182. [DOI] [PubMed] [Google Scholar]
- 35.Lu M, Zheng L, Han B, Wang L, Wang P, Liu H, et al. REST regulates DYRK1A transcription in a negative feedback loop. J Biol Chem. 2011;286:10755–63. doi: 10.1074/jbc.M110.174540. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Guardavaccaro D, Frescas D, Dorrello NV, Peschiaroli A, Multani AS, Cardozo T, et al. Control of chromosome stability by the beta-TrCP-REST-Mad2 axis. Nature. 2008;452:365–9. doi: 10.1038/nature06641. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Canzonetta C, Mulligan C, Deutsch S, Ruf S, O’Doherty A, Lyle R, et al. DYRK1A-dosage imbalance perturbs NRSF/REST levels, deregulating pluripotency and embryonic stem cell fate in Down syndrome. Am J Hum Genet. 2008;83:388–400. doi: 10.1016/j.ajhg.2008.08.012. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Skurat AV, Dietrich AD. Phosphorylation of Ser640 in muscle glycogen synthase by DYRK family protein kinases. J Biol Chem. 2004;279:2490–8. doi: 10.1074/jbc.M301769200. [DOI] [PubMed] [Google Scholar]
- 39.Mazmanian G, Kovshilovsky M, Yen D, Mohanty A, Mohanty S, Nee A, et al. The zebrafish dyrk1b gene is important for endoderm formation. Genesis. 2010;48:20–30. doi: 10.1002/dvg.20578. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Ritterhoff S, Farah CM, Grabitzki J, Lochnit G, Skurat AV, Schmitz ML. The WD40-repeat protein Han11 functions as a scaffold protein to control HIPK2 and MEKK1 kinase functions. EMBO J. 2010;29:3750–61. doi: 10.1038/emboj.2010.251. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Miyata Y, Nishida E. DYRK1A binds to an evolutionarily conserved WD40-repeat protein WDR68 and induces its nuclear translocation. Biochim Biophys Acta. 20111813:1728–39. doi: 10.1016/j.bbamcr.2011.06.023. [DOI] [PubMed] [Google Scholar]
- 42.Lee J, Zhou P. DCAFs, the missing link of the CUL4-DDB1 ubiquitin ligase. Mol Cell. 2007;26:775–80. doi: 10.1016/j.molcel.2007.06.001. [DOI] [PubMed] [Google Scholar]
- 43.de Graaf K, Hekerman P, Spelten O, Herrmann A, Packman LC, Büssow K, et al. Characterization of cyclin L2, a novel cyclin with an arginine/serine-rich domain: phosphorylation by DYRK1A and colocalization with splicing factors. J Biol Chem. 2004;279:4612–24. doi: 10.1074/jbc.M310794200. [DOI] [PubMed] [Google Scholar]
- 44.Pei XH, Bai F, Li Z, Smith MD, Whitewolf G, Jin R, et al. Cytoplasmic CUL9/PARC ubiquitin ligase is a tumor suppressor and promotes p53-dependent apoptosis. Cancer Res. 2011;71:2969–77. doi: 10.1158/0008-5472.CAN-10-4300. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Vervoorts J, Lüscher B. Post-translational regulation of the tumor suppressor p27(KIP1) Cell Mol Life Sci. 2008;65:3255–64. doi: 10.1007/s00018-008-8296-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Susaki E, Nakayama KI. Multiple mechanisms for p27(Kip1) translocation and degradation. Cell Cycle. 2007;6:3015–20. doi: 10.4161/cc.6.24.5087. [DOI] [PubMed] [Google Scholar]
- 47.Pierantoni GM, Esposito F, Tornincasa M, Rinaldo C, Viglietto G, Soddu S, et al. Homeodomain-interacting protein kinase-2 stabilizes p27(kip1) by its phosphorylation at serine 10 and contributes to cell motility. J Biol Chem. 2011;286:29005–13. doi: 10.1074/jbc.M111.230854. [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]
- 48.Liang YJ, Chang HS, Wang CY, Yu WC. DYRK1A stabilizes HPV16E7 oncoprotein through phosphorylation of the threonine 5 and threonine 7 residues. Int J Biochem Cell Biol. 2008;40:2431–41. doi: 10.1016/j.biocel.2008.04.003. [DOI] [PubMed] [Google Scholar]
- 49.Garrett S, Menold MM, Broach JR. The Saccharomyces cerevisiae YAK1 gene encodes a protein kinase that is induced by arrest early in the cell cycle. Mol Cell Biol. 1991;11:4045–52. doi: 10.1128/mcb.11.8.4045. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Jaspersen SL, Charles JF, Tinker-Kulberg RL, Morgan DO. A late mitotic regulatory network controlling cyclin destruction in Saccharomyces cerevisiae. Mol Biol Cell. 1998;9:2803–17. doi: 10.1091/mbc.9.10.2803. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Uetz P, Giot L, Cagney G, Mansfield TA, Judson RS, Knight JR, et al. A comprehensive analysis of protein-protein interactions in Saccharomyces cerevisiae. Nature. 2000;403:623–7. doi: 10.1038/35001009. [DOI] [PubMed] [Google Scholar]
- 52.Taira N, Nihira K, Yamaguchi T, Miki Y, Yoshida K. DYRK2 is targeted to the nucleus and controls p53 via Ser46 phosphorylation in the apoptotic response to DNA damage. Mol Cell. 2007;25:725–38. doi: 10.1016/j.molcel.2007.02.007. [DOI] [PubMed] [Google Scholar]
- 53.Hämmerle B, Ulin E, Guimera J, Becker W, Guillemot F, Tejedor FJ. Transient expression of Mnb/Dyrk1a couples cell cycle exit and differentiation of neuronal precursors by inducing p27KIP1 expression and suppressing NOTCH signaling. Development. 2011;138:2543–54. doi: 10.1242/dev.066167. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Kurabayashi N, Hirota T, Sakai M, Sanada K, Fukada Y. DYRK1A and glycogen synthase kinase 3beta, a dual-kinase mechanism directing proteasomal degradation of CRY2 for circadian timekeeping. Mol Cell Biol. 2010;30:1757–68. doi: 10.1128/MCB.01047-09. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Zhang Q, Nottke A, Goodman RH. Homeodomain-interacting protein kinase-2 mediates CtBP phosphorylation and degradation in UV-triggered apoptosis. Proc Natl Acad Sci USA. 2005;102:2802–7. doi: 10.1073/pnas.0409373102. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.Yamada D, Pérez-Torrado R, Filion G, Caly M, Jammart B, Devignot V, et al. The human protein kinase HIPK2 phosphorylates and downregulates the methyl-binding transcription factor ZBTB4. Oncogene. 2009;28:2535–44. doi: 10.1038/onc.2009.109. [DOI] [PubMed] [Google Scholar]
- 57.Lazzari C, Prodosmo A, Siepi F, Rinaldo C, Galli F, Gentileschi M, et al. HIPK2 phosphorylates ΔNp63α and promotes its degradation in response to DNA damage. Oncogene. 2011;30:4802–13. doi: 10.1038/onc.2011.182. [DOI] [PubMed] [Google Scholar]
- 58.Kim EA, Kim JE, Sung KS, Choi DW, Lee BJ, Choi CY. Homeodomain-interacting protein kinase 2 (HIPK2) targets beta-catenin for phosphorylation and proteasomal degradation. Biochem Biophys Res Commun. 2010;394:966–71. doi: 10.1016/j.bbrc.2010.03.099. [DOI] [PubMed] [Google Scholar]
- 59.Calzado MA, De La Vega L, Munoz E, Schmitz ML. From top to bottom: the two faces of HIPK2 for regulation of the hypoxic response. Cell Cycle. 2009;8:1659–64. doi: 10.4161/cc.8.11.8597. [DOI] [PubMed] [Google Scholar]
- 60.Ryu YS, Park SY, Jung MS, Yoon SH, Kwen MY, Lee SY, et al. Dyrk1A-mediated phosphorylation of Presenilin 1: a functional link between Down syndrome and Alzheimer’s disease. J Neurochem. 2010;115:574–84. doi: 10.1111/j.1471-4159.2010.06769.x. [DOI] [PubMed] [Google Scholar]
- 61.Jung MS, Park JH, Ryu YS, Choi SH, Yoon SH, Kwen MY, et al. Regulation of RCAN1 protein activity by Dyrk1A protein-mediated phosphorylation. J Biol Chem. 2011;286:40401–12. doi: 10.1074/jbc.M111.253971. [DOI] [PMC free article] [PubMed] [Google Scholar]